NCT01358877 · Interventional trial
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
Overall registry status Completed
Phase 3
Conditions Breast Cancer
Delaware Valley sites
- Abramson Cancer Center · Philadelphia, PA · Philadelphia County
- Albert Einstein Healthcare Network · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory